PBI logo

PBI

Pitney Bowes Inc.

$15.51
+$0.26(+1.70%)
65
Overall
80
Value
60
Tech
57
Quality
How is this score calculated?
Market Cap
$2.11B
Volume
2.37M
52W Range
$8.95 - $15.95
Target Price
$16.74

Latest News for PBI

Pitney Bowes Extends Credit Facilities, Tightens Covenants
TipRanks Auto-Generated Newsdesk7 days agoMay 19, 2026

Pitney Bowes ( ($PBI) ) has provided an announcement. On May 18, 2026, Pitney Bowes amended its credit agreement, extending the maturities of its $......

Paradigm Biopharmaceuticals sets June in‑person shareholder meeting with digital proxy push
TipRanks Australian Auto-Generated Newsdesk15 days agoMay 12, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has called a General Meeting of shareholders t......

Pitney Bowes Earnings Call Signals Cautious Turnaround
TipRanks Auto-Generated Newsdesk20 days agoMay 07, 2026

Pitney Bowes (($PBI)) has held its Q1 earnings call. Read on for the main highlights of the call. Pitney Bowes struck an upbeat tone on its latest ......

Pitney Bowes Earnings Call Signals Cautious Turnaround
TipRanks Auto-Generated Newsdesk20 days agoMay 07, 2026

Pitney Bowes (($PBI)) has held its Q1 earnings call. Read on for the main highlights of the call. Pitney Bowes struck an upbeat tone on its latest ......

Paradigm Biopharmaceuticals Launches $2m Share Purchase Plan After $14m Placement
TipRanks Australian Auto-Generated Newsdeska month agoApr 30, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has completed a $14 million placement of 73,68......

Paradigm Hits 50% Dosing in Global Knee OA Trial and Bolsters Funding
TipRanks Australian Auto-Generated Newsdeska month agoApr 27, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an update. Paradigm Biopharmaceuticals reported continued momentum in its global Phase 3 tr......

Paradigm Biopharmaceuticals Launches Securities Purchase Plan With Options Package
TipRanks Australian Auto-Generated Newsdeska month agoApr 27, 2026

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has provided an update. Paradigm Biopharmaceuticals has announced a proposed securities purchase plan, un......

Paradigm Biopharmaceuticals Plans Major Share and Option Issue to Boost Capital
TipRanks Australian Auto-Generated Newsdeska month agoApr 27, 2026

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has outlined a proposed capital raising ......

Paradigm boosts funding to carry Phase 3 trial through key interim data
TipRanks Australian Auto-Generated Newsdeska month agoApr 27, 2026

An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a significantly upsized A$14 m......

News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.

ABCD
1SymbolPriceChangeVol
2PBI$15.51+1.7%2.37M
3
4
5
6

Get Pitney Bowes Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.